KALA BIO KALA 深 滬
已收盤 07-31 16:00:00 美东时间
0.7559
+0.026
+3.59%
華盛通- 最 高0.7875
- 今 開0.732
- 成交量 7.17万股
- 最 低 0.67
- 昨 收 0.7297
- 總市值 1461.89万
- 52周最高 1030.00
- 市盈率 靜 --
- 換手率 0.37%
- 52周最低 0.59
- 委 比 0.00%
- 總股本 1933.98万
- 歷史最高 66875.00
- 量 比 0.93
- 振 幅 16.10%
- 歷史最低 0.67
- 每 手 1
- 風險率 237.77%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kala Bio Files Prospectus Supplement for New Securities Offering
An update from KALA BIO ( ($KALA) ) is now available. On July 22, 2026, Kala Bi...
07-23 18:35
Kala Bio Q1 EPS $(0.14) Beats $(0.30) Estimate
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.30) by 53.33 percent. This is a 99.8 percent increase over losses of $(70.49) per share from the same
05-16 07:12
KALA BIO shares are trading lower after the company announced a 1-for-50 reverse stock split.
KALA BIO shares are trading lower after the company announced a 1-for-50 revers...
05-07 21:24
Kala Bio Announces 1-For-50 Reverse Stock Split, Effective May 11
KALA BIO, Inc. (NASDAQ: KALA) ("KALA BIO" or the "Company"), today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the "common stock") at a ratio of 1 post-split
05-07 21:03
Kala Bio Q4 EPS $0.86 Beats $(1.44) Estimate, Sales $0.00
Kala Bio (NASDAQ:KALA) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $(1.44) by 159.72 percent. This is a 149.43 percent increase over losses of $(1.74) per share from the
04-16 05:26
Top 3 Health Care Stocks Which Could Blast Off This Quarter
Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen Inc (PEPG), KALA BIO Inc (KALA), Viridian Therapeutics Inc (VRDN)
04-08 18:40
Kala Bio Highlights Launch Of Agentic AI Platform
The Bionic Intelligence Research Agent is a fully autonomous AI research specialist built for the biotechnology and pharmaceutical sectors
03-30 20:32
EXCLUSIVE: Penny Stock Kala Bio Transitions To Revenue Model With AI Platform Launch
Kala Bio launches BIRA AI agent for biotech research, marking a shift to commercial deployment and a potential recurring revenue model.
03-30 20:31
美股牛股 | OCUGEN飙升近30%，机构首次覆盖该公司并给予高额目标价；纳微半导体大涨近25%
OCUGEN飙升近30%，机构首次覆盖该公司并给予高额目标价；纳微半导体大涨近25%，推出适用于人工智能数据中心的两款新产品>>
03-12 16:40
Kala Bio Chases 'Palantir For Biotech' Dream With New AI Platform
Is KALA the Palantir of biotech? Kala Bio Inc. pivots to agentic AI with a new platform shipping in 2 weeks. Read the full update.
03-11 20:08
